Laman UtamaRGLS • NASDAQ
add
Regulus Therapeutics Inc
Tutup sebelumnya
$1.41
Julat hari
$1.31 - $1.49
Julat tahun
$1.08 - $3.79
Permodalan pasaran
85.87J USD
Bilangan Purata
271.42K
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Hasil | — | — |
Perbelanjaan pengendalian | 14.19J | 81.62% |
Pendapatan bersih | -14.06J | -79.73% |
Margin untung bersih | — | — |
Pendapatan bagi setiap syer | -0.21 | 47.50% |
EBITDA | -15.12J | -87.38% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 87.31J | 183.64% |
Jumlah aset | 93.76J | 148.40% |
Jumlah liabiliti | 6.96J | -26.67% |
Jumlah ekuiti | 86.80J | — |
Syer tertunggak | 65.50J | — |
Harga kepada buku | 1.06 | — |
Pulangan pada aset | -38.43% | — |
Pulangan pada modal | -40.53% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -14.06J | -79.73% |
Tunai daripada operasi | -9.45J | -50.53% |
Tunai daripada pelaburan | 18.64J | 442.72% |
Tunai daripada pembiayaan | 56.00K | -80.49% |
Perubahan bersih dalam tunai | 9.25J | 180.94% |
Aliran tunai bebas | -4.32J | -55.64% |
Perihal
Regulus Therapeutics Inc. is a clinical stage biopharmaceutical company focused on the development of first-in-class drugs that target microRNAs to treat a broad range of diseases. Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals. Wikipedia
Diasaskan
Sep 2007
Tapak web
Pekerja
32
